Yahoo Web Search

  1. Ads
    related to JOHNSON & JOHNSON
  1. Yahoo Finance Results

  2. Better Buy: Johnson & Johnson vs. Pfizer

    Motley Fool via Yahoo FinanceAug 02 10:32 AM

    Johnson & Johnson's solid Q2 performance highlights several reasons to like the stock. Another thing Johnson & Johnson's second-quarter results show is the company's ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting JNJ. Index (PMI) data, output in the Healthcare sector is rising.

    134.47+1.99 (+1.50%)

    at Fri, Aug 17, 2018, 15:00PM EST - U.S. Markets closed

    After Hours 134.40 -0.07 (-0.05%)

    Delayed Quote

    • Open 132.45
    • High 135.00
    • Low 132.19
    • Prev. Close 132.48
    • 52 Wk. High 148.32
    • 52 Wk. Low 118.62
    • P/E 267.34
    • Mkt. Cap 360.75B
  4. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on July 12.

  5. Johnson Controls (JCI) just came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.80 per share. This quarterly report represents an earnings ...

  6. DeWayne Johnson listens during the Monsanto trial in San Francisco last month. Monsanto suffered a major blow with a jury ruling that the company was liable for a terminally ill man’s ...

  7. Johnson Controls International plc JCI reported adjusted earnings per share of 81 cents in third-quarter fiscal 2018, beating the Zacks Consensus Estimate of 80 cents. Moreover, earnings ...

  8. I will turn the call over to Antonella Franzen, Vice President and Chief Investor Relations and Communications Officer. Good morning and thank you for joining our conference call to discuss Johnson Controls' Third Quarter Fiscal 2018 Results.

  9. Johnson Outdoor (JOUT) just came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.88 per share. This quarterly report represents an earnings ...

  10. Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down

    Zacks via Yahoo FinanceAug 01 20:48 PM

    Shares were down 5% in pre-market trading on Aug 1, presumably due to lack of clarity on Janssen’s, a subsidiary of Johnson & Johnson JNJ, decision to pursue imetelstat development ...

  1. Ad
    related to JOHNSON & JOHNSON